RRS HA CELLUTRIX 1x10 ml
17 EUR
1x10 ml
RRS® HA Cellurix is a product for mesotherapy, used for cellulite reduction and skin tightening as well as for localized fat reduction. It is used to smooth out irregularities on the skin's surface using a specific biorevitalizing solution.
RRS® HA Cellutrix is a Class III medical device - CE mark 1014, intended for injection.
RRS® HA Cellutrix can be used on areas:
- chin,
- buttocks,
- back of the thigh,
- back,
- abdomen.
For whom: no age limit.
Injection technique: microdeposit technique, distance between injections 2-3 cm, volume of 1 dose is 0.1/0.2 ml.
Recommended needle size: 32G.
Best results are achieved after 4-6 treatments performed once a week. Such a session can be repeated from one to three times a year.
Combination with other treatments:
- peeling - injection with RRS® product first.
INDICATIONS
- cellulite reduction,
- firming of skin affected by cellulite,
- localized accumulation of fat - local fat corrector,
- improvement of skin quality.
ACTIVE INGREDIENTS
- 0.05 mg/ml HA hyaluronic acid 17.5 mg/ml biostimulating cocktail,
- 8 antioxidants: vitamin C, triferulic acid, Irbic acid, Iso-Benzofuranones,-hedera, Hederasaponin C, Hederacolchiside E and F,
- 2 lipolytics: fucoxanthin, caffeine,
- 7 flavonoids: cinaroside, cinaratrioside, quercetin, kaempferol, troxerutin, rutin, hesperidin,
- 8 microelements: I, K, Br, Cl, Ca, Fe, Si, Mg,
- 3 vitamins: C, A, B2,
- 8 saponins: ruscogenins, neoruscogenin, α-hederin, hederasaponin C, hederacolchiside E and F, asiaticoside, madecassoside,
- 3 triterpenes: asiatic acid, madecassic acid, amber acid,
- 1 amino acid: L-carnitine,
- 2 AHAs: malic acid, lactic acid,
- 2 polyphenols: chlorogenic acid, Phloroglucinol,
- lipolytic ingredient: caffeine and fucoxanthin.
PACKAGING
The price is for 1 vial of 10 ml of the product.
The entire package contains 6 vials of 10 ml of the product each.
CONTRAINDICATIONS
- pregnancy and breastfeeding,
- areas with inflammatory skin problems (acne, herpes),
- diabetes,
- skin intolerant to injections (vascular skin, risk of scarring),
- autoimmune diseases,
- allergies,
- bleeding disorders,
- use of anticoagulant drugs (e.g., aspirin).